{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:57:47Z","timestamp":1790859467404,"version":"4.1.0"},"reference-count":190,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270855"],"award-info":[{"award-number":["82270855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jceh.2024.102459","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T21:34:03Z","timestamp":1732052043000},"page":"102459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?"],"prefix":"10.1016","volume":"15","author":[{"given":"Huiyan","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2024.102459_bib1","doi-asserted-by":"crossref","first-page":"ITC65","DOI":"10.7326\/AITC201811060","article-title":"Nonalcoholic fatty liver disease","volume":"169","author":"Wan","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2024.102459_bib2","first-page":"1682","article-title":"Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis","volume":"135","author":"Liu","year":"2022","journal-title":"Chin Med J (Engl)."},{"issue":"suppl l","key":"10.1016\/j.jceh.2024.102459_bib3","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: how is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib4","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1097\/HEP.0000000000000696","article-title":"Reply: a multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Lazarus","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102459_bib5","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.102459_bib6","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2024.102459_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2009","journal-title":"QJM"},{"key":"10.1016\/j.jceh.2024.102459_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2024.102459_bib9","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cgh.2017.11.045","article-title":"Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.102459_bib11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"suppl l","key":"10.1016\/j.jceh.2024.102459_bib12","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of non-alcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib13","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jceh.2024.102459_bib14","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1172\/JCI9575","article-title":"Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice","volume":"105","author":"Nemoto","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2024.102459_bib15","doi-asserted-by":"crossref","first-page":"G1031","DOI":"10.1152\/ajpgi.00211.2011","article-title":"Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet","volume":"301","author":"Kamada","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2024.102459_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF03401306","article-title":"Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2013","journal-title":"Hormones (Basel)"},{"key":"10.1016\/j.jceh.2024.102459_bib17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.cgh.2014.12.033","article-title":"Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis","volume":"13","author":"Lazo","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A\u00a0potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod Health"},{"key":"10.1016\/j.jceh.2024.102459_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","article-title":"Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"16","author":"Jaruvongvanich","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/jc.2018-00740","article-title":"Sex hormone-binding globulin expression correlates with acetyl-coenzyme A carboxylase and triglyceride content in human liver","volume":"104","author":"S\u00e1ez-L\u00f3pez","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2024.102459_bib21","doi-asserted-by":"crossref","first-page":"E974","DOI":"10.1152\/ajpendo.00200.2016","article-title":"Chronic hyperprolactinemia evoked by disruption of lactotrope dopamine D2 receptors impacts on liver and adipocyte genes related to glucose and insulin balance","volume":"311","author":"Luque","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jceh.2024.102459_bib22","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2018.01.035","article-title":"Prolactin improves hepatic steatosis via CD36 pathway","volume":"68","author":"Zhang","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib23","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/jgh.13271","article-title":"Follicle-stimulating hormone is associated with non-alcoholic fatty liver disease in Chinese women over 55 years old","volume":"31","author":"Wang","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-28032013000200032","article-title":"Nonalcoholic fatty liver disease in menopausal women","volume":"50","author":"Florentino","year":"2013","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.jceh.2024.102459_bib25","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1007\/s10620-015-3660-6","article-title":"Raloxifene ameliorates liver fibrosis of nonalcoholic steatohepatitis induced by choline-deficient high-fat diet in ovariectomized mice","volume":"60","author":"Luo","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2024.102459_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2012-1055","article-title":"The role of estrogens in control of energy balance and glucose homeostasis","volume":"34","author":"Mauvais-Jarvis","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jceh.2024.102459_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fendo.2020.00148","article-title":"Does GPER really function as a G protein-coupled estrogen receptor in\u00a0vivo?","volume":"11","author":"Luo","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib28","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1038\/s41467-021-27272-x","article-title":"Dietary essential amino acids restore liver metabolism in ovariectomized mice via hepatic estrogen receptor alpha","volume":"12","author":"Della Torre","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jceh.2024.102459_bib29","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1006\/bbrc.2001.5479","article-title":"Hepatic stellate cells contain the functional estrogen receptor beta but not the estrogen receptor alpha in male and female rats","volume":"286","author":"Zhou","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2024.102459_bib30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jgh.13976","article-title":"Estrogen receptor beta selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells","volume":"33","author":"Zhang","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib31","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1038\/s41388-018-0631-3","article-title":"Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor","volume":"38","author":"Cortes","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.jceh.2024.102459_bib32","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ijo.2017.50","article-title":"Hormone signaling and fatty liver in females: analysis of estrogen receptor alpha mutant mice","volume":"41","author":"Hart-Unger","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.jceh.2024.102459_bib33","doi-asserted-by":"crossref","first-page":"12729","DOI":"10.1073\/pnas.97.23.12729","article-title":"Increased adipose tissue in male and female estrogen receptor-alpha knockout mice","volume":"97","author":"Heine","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jceh.2024.102459_bib34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.celrep.2016.03.019","article-title":"An essential role for liver ERalpha in coupling hepatic metabolism to the reproductive cycle","volume":"15","author":"Della","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jceh.2024.102459_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004013","article-title":"Estrogen reduces lipid content in the liver exclusively from membrane receptor signaling","volume":"6","author":"Pedram","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.jceh.2024.102459_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057458","article-title":"Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action","volume":"8","author":"Matic","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2024.102459_bib37","first-page":"121","article-title":"Turner syndrome: a pediatric diagnosis frequently made by non-pediatricians","volume":"86","author":"Carvalho","year":"2010","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jceh.2024.102459_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.steroids.2017.10.015","article-title":"Estrogens and female liver health","volume":"133","author":"Chen","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.jceh.2024.102459_bib39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.102459_bib40","doi-asserted-by":"crossref","first-page":"11806","DOI":"10.1073\/pnas.1205797109","article-title":"Tetradian oscillation of estrogen receptor alpha is necessary to prevent liver lipid deposition","volume":"109","author":"Villa","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jceh.2024.102459_bib41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2024.102459_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrendo.2013.203","article-title":"Energy metabolism and fertility: a balance preserved for female health","volume":"10","author":"Della","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jceh.2024.102459_bib44","doi-asserted-by":"crossref","first-page":"E904","DOI":"10.1152\/ajpendo.90248.2008","article-title":"Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice","volume":"295","author":"Bryzgalova","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jceh.2024.102459_bib45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF02899424","article-title":"Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells","volume":"59","author":"Ramadori","year":"1990","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.jceh.2024.102459_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/gut.44.1.127","article-title":"Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in\u00a0vivo and in\u00a0vitro","volume":"44","author":"Shimizu","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2024.102459_bib47","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jnutbio.2010.06.005","article-title":"Liver AMP\/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose","volume":"22","author":"Vila","year":"2011","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.jceh.2024.102459_bib48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.jceh.2024.102459_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/db11-1718","article-title":"Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance","volume":"62","author":"Zhu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2024.102459_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1152\/japplphysiol.00440.2014","article-title":"Intensity-dependent and sex-specific alterations in hepatic triglyceride metabolism in mice following acute exercise","volume":"118","author":"Tuazon","year":"2015","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.jceh.2024.102459_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tips.2013.01.009","article-title":"Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria","volume":"34","author":"Han","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jceh.2024.102459_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2012.06.004","article-title":"A\u00a0liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches","volume":"143","author":"Seki","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.102459_bib53","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/hep.29689","article-title":"New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases","volume":"67","author":"Win","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102459_bib54","doi-asserted-by":"crossref","first-page":"35071","DOI":"10.1074\/jbc.M111.276089","article-title":"c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice","volume":"286","author":"Win","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2024.102459_bib55","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/hep.28486","article-title":"c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src","volume":"63","author":"Win","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102459_bib56","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1172\/JCI128289","article-title":"Expression of mitochondrial membrane-linked SAB determines severity of sex-dependent acute liver injury","volume":"129","author":"Win","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2024.102459_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib58","first-page":"603","article-title":"PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver","volume":"141","author":"Abdelmegeed","year":"2011","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jceh.2024.102459_bib59","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metabol"},{"key":"10.1016\/j.jceh.2024.102459_bib60","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPARalpha gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib61","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2004.09.110","article-title":"PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats","volume":"324","author":"Toyama","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2024.102459_bib62","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/hep.20170","article-title":"Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice","volume":"39","author":"Ip","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102459_bib63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/jhep.2003.50307","article-title":"Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice","volume":"38","author":"Ip","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102459_bib64","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00394-009-0037-7","article-title":"Hepatic lipid metabolism response to dietary fatty acids is differently modulated by PPARalpha in male and female mice","volume":"48","author":"Morise","year":"2009","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jceh.2024.102459_bib65","first-page":"257","article-title":"Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation","volume":"1","author":"Karashima","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2024.102459_bib66","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM198812293192601","article-title":"Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women","volume":"319","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2024.102459_bib67","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(05)78493-2","article-title":"Tamoxifen-induced fatty liver in patients with breast cancer","volume":"351","author":"Ogawa","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2024.102459_bib68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0168-8278(95)80316-5","article-title":"Tamoxifen-associated steatohepatitis--report of three cases","volume":"23","author":"Pinto","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib69","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(05)75907-9","article-title":"Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis","volume":"353","author":"Saibara","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2024.102459_bib70","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/emm.2002.67","article-title":"Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism","volume":"34","author":"Yoon","year":"2002","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jceh.2024.102459_bib71","first-page":"794","article-title":"Signaling cross-talk between peroxisome proliferator-activated receptor\/retinoid X receptor and estrogen receptor through estrogen response elements","volume":"9","author":"Keller","year":"1995","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7570\/jomes23054","article-title":"Mitochondrial quality control: its role in metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"32","author":"Shin","year":"2023","journal-title":"J\u00a0Obes Metab Syndr"},{"key":"10.1016\/j.jceh.2024.102459_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.gastro.2016.09.017","article-title":"Estrogen signals through peroxisome proliferator-activated receptor-gamma coactivator 1alpha to reduce oxidative damage associated with diet-induced fatty liver disease","volume":"152","author":"Besse-Patin","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.102459_bib74","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2337\/db08-1571","article-title":"Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression","volume":"58","author":"Estall","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2024.102459_bib75","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metabol"},{"key":"10.1016\/j.jceh.2024.102459_bib76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41575-018-0089-3","article-title":"Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators","volume":"16","author":"Piccinin","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib77","doi-asserted-by":"crossref","first-page":"G979","DOI":"10.1152\/ajpgi.00169.2012","article-title":"PGC-1alpha overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion","volume":"303","author":"Morris","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2024.102459_bib78","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.26222","article-title":"Hepatic-specific activation of peroxisome proliferator-activated receptor gamma coactivator-1beta protects against steatohepatitis","volume":"57","author":"Bellafante","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102459_bib79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.08.016","article-title":"Intracrine androgen biosynthesis, metabolism and action revisited","volume":"465","author":"Schiffer","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib80","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2024.102459_bib81","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jsbmb.2013.04.001","article-title":"Androgen (dihydrotestosterone)-mediated regulation of food intake and obesity in female mice","volume":"138","author":"Kanaya","year":"2013","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jceh.2024.102459_bib82","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ajg.2017.44","article-title":"Testosterone levels in pre-menopausal women are associated with nonalcoholic fatty\u00a0liver disease in midlife","volume":"112","author":"Sarkar","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.102459_bib83","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/dmrr.872","article-title":"Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?","volume":"24","author":"Corbould","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jceh.2024.102459_bib84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/hr.2015.129","article-title":"Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation","volume":"39","author":"Karashima","year":"2016","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jceh.2024.102459_bib85","first-page":"952","article-title":"The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women","volume":"81","author":"Moghetti","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2024.102459_bib86","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/ERC-12-0401","article-title":"In\u00a0vitro model systems to study androgen receptor signaling in prostate cancer","volume":"20","author":"Sampson","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jceh.2024.102459_bib87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2011.09.046","article-title":"Androgen action and metabolism in prostate cancer","volume":"360","author":"Green","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105829","article-title":"Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats","volume":"208","author":"Cui","year":"2021","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jceh.2024.102459_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116940","article-title":"Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome","volume":"236","author":"Wang","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.jceh.2024.102459_bib90","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-kappaB in the liver--linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib91","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1053\/j.gastro.2009.02.081","article-title":"Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis","volume":"136","author":"Oakley","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.102459_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13451-8","article-title":"Impaired branched-chain amino acid metabolism may underlie the nonalcoholic fatty liver disease-like pathology of neonatal testosterone-treated female rats","volume":"7","author":"Anzai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2024.102459_bib93","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2016.09.162","article-title":"BCKA down-regulates mTORC2-Akt signal and enhances apoptosis susceptibility in cardiomyocytes","volume":"480","author":"Guo","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.jceh.2024.102459_bib94","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138889","article-title":"Adipose tissue dysfunction and altered systemic amino acid metabolism are associated with non-alcoholic fatty liver disease","volume":"10","author":"Cheng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2024.102459_bib96","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/JOE-21-0040","article-title":"DHT causes liver steatosis via transcriptional regulation of SCAP in normal weight female mice","volume":"250","author":"Seidu","year":"2021","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib97","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/hep.22907","article-title":"A\u00a0novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte","volume":"49","author":"Moreau","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102459_bib98","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1074\/jbc.271.17.10379","article-title":"Regulated cleavage of sterol regulatory element binding proteins requires sequences on both sides of the endoplasmic reticulum membrane","volume":"271","author":"Hua","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2024.102459_bib99","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2015.09.021","article-title":"Glucose-mediated N-glycosylation of SCAP is essential for SREBP-1 activation and tumor growth","volume":"28","author":"Cheng","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jceh.2024.102459_bib100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2009.09.020","article-title":"Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome","volume":"316","author":"Pugeat","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib101","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ije\/dyq158","article-title":"Testosterone, sex hormone-binding globulin and\u00a0the metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"40","author":"Brand","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jceh.2024.102459_bib102","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMoa0804381","article-title":"Sex hormone-binding globulin and risk of type 2 diabetes in women and men","volume":"361","author":"Ding","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2024.102459_bib103","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Lim","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.jceh.2024.102459_bib104","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/cob.12132","article-title":"Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome","volume":"6","author":"Qureshi","year":"2016","journal-title":"Clin Obes"},{"key":"10.1016\/j.jceh.2024.102459_bib105","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.annepidem.2007.05.013","article-title":"Nonalcoholic fatty liver disease","volume":"17","author":"Adams","year":"2007","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jceh.2024.102459_bib106","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ijc.28342","article-title":"Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?","volume":"134","author":"Lukanova","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jceh.2024.102459_bib107","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cen.14459","article-title":"Relationship between de novo lipogenesis and serum sex hormone binding globulin in humans","volume":"95","author":"Simons","year":"2021","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib108","first-page":"3979","article-title":"Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene","volume":"117","author":"Selva","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2024.102459_bib109","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.tem.2015.05.001","article-title":"Novel insights in SHBG regulation and clinical implications","volume":"26","author":"Simo","year":"2015","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.jceh.2024.102459_bib110","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db11-0727","article-title":"Potential role of tumor necrosis factor-alpha in downregulating sex hormone-binding globulin","volume":"61","author":"Simo","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2024.102459_bib111","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/me.2011-1321","article-title":"Molecular mechanism of TNFalpha-induced down-regulation of SHBG expression","volume":"26","author":"Simo","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib112","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1210\/me.2012-1152","article-title":"IL1beta down-regulation of sex hormone-binding globulin production by decreasing HNF-4alpha via MEK-1\/2 and JNK MAPK pathways","volume":"26","author":"Simo","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib113","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/j.2040-4603.2018.tb00036.x","article-title":"Adiponectin regulation and function","volume":"8","author":"Fang","year":"2018","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jceh.2024.102459_bib114","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.bbrc.2005.06.187","article-title":"Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors","volume":"334","author":"Neumeier","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2024.102459_bib115","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1478-3231.2009.02022.x","article-title":"Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease","volume":"29","author":"Lemoine","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2024.102459_bib116","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1210\/en.2014-1072","article-title":"Adiponectin upregulates SHBG production: molecular mechanisms and potential implications","volume":"155","author":"Simo","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jceh.2024.102459_bib117","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2337\/db10-0179","article-title":"Relationships of circulating sex hormone-binding globulin with metabolic traits in humans","volume":"59","author":"Peter","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2024.102459_bib118","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.metabol.2009.06.033","article-title":"Sex hormone-binding globulin and lipid profile in pubertal children","volume":"59","author":"Garces","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2024.102459_bib119","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2024.102459_bib120","first-page":"545","article-title":"Sex hormone-binding globulin reduction in metabolic disorders may play a role in NAFLD development","volume":"158","author":"S\u00e1ez-L\u00f3pez","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.jceh.2024.102459_bib121","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2018.01.034","article-title":"Diurnal rhythm of follicle-stimulating hormone is associated with nonalcoholic fatty liver disease in a Chinese elderly population","volume":"222","author":"Li","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jceh.2024.102459_bib122","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0303-7207(94)03444-X","article-title":"Ontogeny of follicle-stimulating hormone receptor gene expression in the rat testis and ovary","volume":"107","author":"Rannikki","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib123","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature22342","article-title":"Blocking FSH induces thermogenic adipose tissue and reduces body fat","volume":"546","author":"Liu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2024.102459_bib124","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/21623945.2020.1870060","article-title":"Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus","volume":"10","author":"Cheng","year":"2021","journal-title":"Adipocyte"},{"key":"10.1016\/j.jceh.2024.102459_bib125","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/oby.20456","article-title":"Blunted metabolic responses to cold and insulin stimulation in brown adipose tissue of obese humans","volume":"21","author":"Orava","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.jceh.2024.102459_bib126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11307-018-1251-6","article-title":"Evaluation of glucose uptake and uncoupling protein 1 activity in adipose tissue of diabetic mice upon beta-adrenergic stimulation","volume":"21","author":"Kubo","year":"2019","journal-title":"Mol Imag Biol"},{"key":"10.1016\/j.jceh.2024.102459_bib127","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.celrep.2013.10.044","article-title":"UCP1 in brite\/beige adipose tissue mitochondria is functionally thermogenic","volume":"5","author":"Shabalina","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.jceh.2024.102459_bib128","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1194\/jlr.M025403","article-title":"FSH stimulates lipid biosynthesis in chicken adipose tissue by upregulating the expression of its receptor FSHR","volume":"53","author":"Cui","year":"2012","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jceh.2024.102459_bib129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbalip.2009.09.024","article-title":"Acyl-CoA synthesis, lipid metabolism and lipotoxicity","volume":"1801","author":"Li","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jceh.2024.102459_bib130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/jc.2015-2724","article-title":"Follicle-stimulating hormone induces postmenopausal dyslipidemia through inhibiting hepatic cholesterol metabolism","volume":"101","author":"Song","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2024.102459_bib131","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s40618-022-01848-w","article-title":"Sex-specific metabolic risk factors and their trajectories towards the non-alcoholic fatty liver disease incidence","volume":"45","author":"Tong","year":"2022","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jceh.2024.102459_bib132","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41422-018-0123-6","article-title":"Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol","volume":"29","author":"Guo","year":"2019","journal-title":"Cell Res"},{"key":"10.1016\/j.jceh.2024.102459_bib133","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.physiol.64.081501.131049","article-title":"Prolactin: the new biology of an old hormone","volume":"64","author":"Goffin","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jceh.2024.102459_bib134","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tem.2006.02.005","article-title":"Focus on prolactin as a metabolic hormone","volume":"17","author":"Ben-Jonathan","year":"2006","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.jceh.2024.102459_bib135","article-title":"J-shaped relationship between serum prolactin and metabolic-associated fatty liver disease in female patients with type 2 diabetes","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib136","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2337\/diabetes.54.7.1968","article-title":"The regulation of fatty acid synthase by STAT5A","volume":"54","author":"Hogan","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2024.102459_bib137","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2024.102459_bib138","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db07-0907","article-title":"Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity","volume":"56","author":"Koonen","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2024.102459_bib139","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bbrc.2018.03.048","article-title":"Ablation of prolactin receptor increases hepatic triglyceride accumulation","volume":"498","author":"Shao","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2024.102459_bib140","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jceh.2024.102459_bib141","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/00365521.2010.539251","article-title":"Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)","volume":"46","author":"Hossain","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.102459_bib142","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jceh.2024.102459_bib144","doi-asserted-by":"crossref","first-page":"64","DOI":"10.14715\/cmb\/2017.63.10.10","article-title":"Hyperandrogenism stimulates inflammation and promote apoptosis of cumulus cells","volume":"63","author":"Xu","year":"2017","journal-title":"Cell Mol Biol (Noisy-Le-Grand)"},{"key":"10.1016\/j.jceh.2024.102459_bib145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1479-5876-11-133","article-title":"Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS)","volume":"11","author":"Baranova","year":"2013","journal-title":"J\u00a0Transl Med"},{"issue":"suppl 7","key":"10.1016\/j.jceh.2024.102459_bib146","first-page":"5","article-title":"Regulation by exercise of skeletal muscle content of mitochondria and GLUT4","volume":"59","author":"Holloszy","year":"2008","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.jceh.2024.102459_bib147","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj5559","article-title":"Induction of lysosomal and mitochondrial biogenesis by AMPK phosphorylation of FNIP1","volume":"380","author":"Malik","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jceh.2024.102459_bib148","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/er.2003-0016","article-title":"Testosterone effects on the breast: implications for testosterone therapy for women","volume":"25","author":"Somboonporn","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jceh.2024.102459_bib149","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2024.102459_bib150","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.jceh.2024.102459_bib151","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.102459_bib152","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10654-019-00526-1","article-title":"Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink","volume":"34","author":"Florio","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jceh.2024.102459_bib153","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/edrv.23.1.0456","article-title":"Changes in proinflammatory cytokine activity after menopause","volume":"23","author":"Pfeilschifter","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jceh.2024.102459_bib154","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.fct.2018.05.006","article-title":"Effects of high fructose intake on liver injury progression in high fat diet induced fatty liver disease in ovariectomized female mice","volume":"118","author":"Ohashi","year":"2018","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jceh.2024.102459_bib155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S8756-3282(01)00468-9","article-title":"The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood","volume":"29","author":"Rogers","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.jceh.2024.102459_bib156","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2741\/e190","article-title":"Changes in the immune system during menopause and aging","volume":"2","author":"Gameiro","year":"2010","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.jceh.2024.102459_bib157","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.maturitas.2014.04.014","article-title":"Probing the impact of sex steroids and menopause-related sex steroid deprivation on modulation of immune senescence","volume":"78","author":"Vrachnis","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.jceh.2024.102459_bib158","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/liv.13735","article-title":"Serum testosterone and non-alcoholic fatty liver disease in men and women in the US","volume":"38","author":"Yim","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2024.102459_bib159","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1089\/jwh.2018.7263","article-title":"Serum testosterone level within normal range is positively associated with nonalcoholic fatty liver disease in premenopausal but not postmenopausal women","volume":"28","author":"Park","year":"2019","journal-title":"J\u00a0Womens Health (Larchmt)."},{"key":"10.1016\/j.jceh.2024.102459_bib160","doi-asserted-by":"crossref","first-page":"35983","DOI":"10.1074\/jbc.M507339200","article-title":"Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways","volume":"280","author":"D'Eon","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2024.102459_bib161","article-title":"The art of hormone replacement therapy (HRT) in menopause management","author":"Cameron","year":"2023","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.jceh.2024.102459_bib162","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2024.102459_bib163","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","article-title":"Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial","volume":"65","author":"McKenzie","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib164","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-28032013000200032","article-title":"Nonalcoholic fatty liver disease in menopausal women","volume":"50","author":"Florentino","year":"2013","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.jceh.2024.102459_bib165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cgh.2016.07.034","article-title":"Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis","volume":"15","author":"Yang","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102459_bib166","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12958-017-0313-y","article-title":"Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome","volume":"15","author":"de Medeiros","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.jceh.2024.102459_bib167","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17512433.2022.2054413","article-title":"Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause","volume":"15","author":"Gerard","year":"2022","journal-title":"Expet Rev Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jceh.2024.102459_bib168","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.contraception.2021.01.001","article-title":"Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone","volume":"103","author":"Klipping","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.jceh.2024.102459_bib169","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12891-016-1344-9","article-title":"Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database","volume":"17","author":"Sato","year":"2016","journal-title":"BMC Muscoskel Disord"},{"key":"10.1016\/j.jceh.2024.102459_bib170","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1185\/030079905X61839","article-title":"Safety assessment of raloxifene over eight years in a clinical trial setting","volume":"21","author":"Martino","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jceh.2024.102459_bib171","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1158\/1078-0432.CCR-12-3771","article-title":"Bazedoxifene exhibits antiestrogenic activity in animal models of tamoxifen-resistant breast cancer: implications for treatment of advanced disease","volume":"19","author":"Wardell","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jceh.2024.102459_bib172","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00198-010-1440-x","article-title":"Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene\/conjugated estrogens (BZA\/CE)","volume":"22","author":"Lindsay","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jceh.2024.102459_bib173","first-page":"621","article-title":"Selective estrogen modulators in menopause","volume":"65","author":"Gambacciani","year":"2013","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.jceh.2024.102459_bib174","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1152\/ajpendo.00653.2013","article-title":"Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract","volume":"307","author":"Barrera","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jceh.2024.102459_bib175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molmet.2013.12.009","article-title":"Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice","volume":"3","author":"Kim","year":"2014","journal-title":"Mol Metabol"},{"key":"10.1016\/j.jceh.2024.102459_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189911","article-title":"Bazedoxifene and conjugated estrogen combination maintains metabolic homeostasis and benefits liver health","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2024.102459_bib177","article-title":"Small molecule-induced complement factor D (adipsin) promotes lipid accumulation and adipocyte differentiation","volume":"11","author":"Song","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2024.102459_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24061076","article-title":"Isoflavones","volume":"24","author":"Krizova","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jceh.2024.102459_bib179","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3177\/jnsv.66.502","article-title":"Health promotion effects of soy isoflavones","volume":"66","author":"Nakai","year":"2020","journal-title":"J\u00a0Nutr Sci Vitaminol"},{"key":"10.1016\/j.jceh.2024.102459_bib180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0301-2115(98)00281-4","article-title":"Phytoestrogens: the \"natural\" selective estrogen receptor modulators?","volume":"85","author":"Brzezinski","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jceh.2024.102459_bib181","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/09637486.2021.1910630","article-title":"Dietary isoflavones intake is inversely associated with non-alcoholic fatty liver disease, hyperlipidaemia and hypertension","volume":"73","author":"Wang","year":"2022","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.jceh.2024.102459_bib182","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.phytochem.2004.03.005","article-title":"Dietary phytoestrogens and health","volume":"65","author":"Cornwell","year":"2004","journal-title":"Phytochemistry"},{"key":"10.1016\/j.jceh.2024.102459_bib183","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.nut.2005.12.014","article-title":"Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets","volume":"22","author":"Lee","year":"2006","journal-title":"Nutrition"},{"key":"10.1016\/j.jceh.2024.102459_bib184","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/509057","article-title":"Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPAR\u03b3 in a Rat Model","volume":"2015","author":"Susutlertpanya","year":"2015","journal-title":"Evid Based Complement Alternat Med."},{"key":"10.1016\/j.jceh.2024.102459_bib185","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3109\/13880209.2013.766896","article-title":"Genistein sensitizes hepatic insulin signaling and modulates lipid regulatory genes through p70 ribosomal S6 kinase-1 inhibition in high-fat-high-fructose diet-fed mice","volume":"51","author":"Arunkumar","year":"2013","journal-title":"Pharm Biol"},{"key":"10.1016\/j.jceh.2024.102459_bib186","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/bjc.2017.323","article-title":"Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death","volume":"117","author":"Li","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jceh.2024.102459_bib187","article-title":"Association between daidzein intake and metabolic associated fatty liver disease: a cross-sectional study from NHANES 2017-2018","volume":"10","author":"Yang","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.jceh.2024.102459_bib188","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/mnfr.201300482","article-title":"Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPARgamma","volume":"58","author":"Sakamoto","year":"2014","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jceh.2024.102459_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173399","article-title":"Daidzein ameliorates LPS-induced hepatocyte injury by inhibiting inflammation and oxidative stress","volume":"885","author":"Yu","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jceh.2024.102459_bib190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ctcp.2008.01.002","article-title":"Adverse effects of phytoestrogens on reproductive health: a report of three cases","volume":"14","author":"Chandrareddy","year":"2008","journal-title":"Compl Ther Clin Pract"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324011265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324011265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:10:24Z","timestamp":1748297424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688324011265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":190,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0973688324011265"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2024.102459","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2024.102459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102459"}}